drugset / Trial / NCT07392580

Intralesional Chemotherapy (IC): Cisplatin + Epinephrine

NCT07392580

Phase 2 Recruiting 20 enrolled University of Miami
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the effects, good and bad, of injecting chemotherapy into recurrent laryngeal squamous cell carcinoma (SCC) tumors.

Timeline

Start
2026-09-01
Primary completion
2031-09-01
Completion
2031-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 1 mg/ml Other
Background Epinephrine injection Unknown Other